Patents

US21 45448 Proteasome enhancers and uses thereof. August 10, 2021
US21 45446 Proteasome enhancers and uses thereof. August 10, 2021
US21 45440 Proteasome enhancers and uses thereof. August 10, 2021
US 2018-62623861A1 Pipecolic esters for inhibition of the proteasome, Jan. 30, 2019
US2018/035869S mall molecule Proteasome Activators and uses thereof, Dec. 13, 2018
US 2018/0282280A1 Quinoline-based proteasome inhibitors and uses thereof, Oct. 4, 2018.
US 62/539,049. Treatment of malignancies. July 31, 2018
US 62/515,403. Enhancement of proteasome activity for the treatment of neurodegenerative diseases. June 5, 2018
US Provisional patent 62/479,805. Quinoline-based proteasome inhibitors. March 31, 2017
US 8,552,206 B2. and European Patent: 03731545.4. NF-kB inhibitors and uses thereof. Oct. 8, 2013
US 8,252,942 B2. Substituted imidazoline compounds. Aug. 12, 2012
US 7,193,079 B1. Preparation of hymendialdisine derivates and use thereof. March 20, 2007
US 6,878,735 B2. Multi-substituted imidazolines and method of use thereof. April 12, 2005